Prospectus

Immunovant, Inc. Filed 2025-01-24 Acc 0001193125-25-012322

Documents 1

2025-01-24 4 Chief Technology Officer sold 2,195 shares at $23.59 ($51,780)
2025-01-24 4 Chief Medical Officer sold 2,657 shares at $23.59 ($62,679)
2025-01-24 8-K Other events
2025-01-24 424B3 Prospectus
2025-01-21 D Notice of Sales of Unregistered Securities
2025-01-17 4 Chief Medical Officer sold 2,383 shares at an average $23.83 ($56,782)
2020-11-12 424B3 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d829025d424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…